BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 20157291)

  • 1. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
    Ziehn MO; Avedisian AA; Tiwari-Woodruff S; Voskuhl RR
    Lab Invest; 2010 May; 90(5):774-86. PubMed ID: 20157291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration.
    Mandolesi G; Grasselli G; Musumeci G; Centonze D
    Neurol Sci; 2010 Nov; 31(Suppl 2):S255-9. PubMed ID: 20635112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one--time administration of encephalitogenic T cells.
    Kurkowska-Jastrzębska I; Swiątkiewicz M; Zaremba M; Cudna A; Piechal A; Pyrzanowska J; Widy-Tyszkiewicz E; Członkowska A
    Neuroscience; 2013 Sep; 248():690-8. PubMed ID: 23806721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease.
    Ziehn MO; Avedisian AA; Dervin SM; O'Dell TJ; Voskuhl RR
    Lab Invest; 2012 Aug; 92(8):1234-45. PubMed ID: 22525427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-Activating Factor Receptors Mediate Excitatory Postsynaptic Hippocampal Injury in Experimental Autoimmune Encephalomyelitis.
    Bellizzi MJ; Geathers JS; Allan KC; Gelbard HA
    J Neurosci; 2016 Jan; 36(4):1336-46. PubMed ID: 26818520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.
    Nisticò R; Mori F; Feligioni M; Nicoletti F; Centonze D
    Philos Trans R Soc Lond B Biol Sci; 2014 Jan; 369(1633):20130162. PubMed ID: 24298163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: the role of kallikrein-kinin system.
    Dutra RC; Moreira EL; Alberti TB; Marcon R; Prediger RD; Calixto JB
    Brain Behav Immun; 2013 Oct; 33():90-101. PubMed ID: 23777652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease.
    Ziehn MO; Avedisian AA; Dervin SM; Umeda EA; O'Dell TJ; Voskuhl RR
    J Neurosci; 2012 Sep; 32(36):12312-24. PubMed ID: 22956822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.
    Bourel J; Planche V; Dubourdieu N; Oliveira A; Séré A; Ducourneau EG; Tible M; Maitre M; Lesté-Lasserre T; Nadjar A; Desmedt A; Ciofi P; Oliet SH; Panatier A; Tourdias T
    Neurobiol Dis; 2021 Dec; 160():105533. PubMed ID: 34673149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
    Nisticò R; Mango D; Mandolesi G; Piccinin S; Berretta N; Pignatelli M; Feligioni M; Musella A; Gentile A; Mori F; Bernardi G; Nicoletti F; Mercuri NB; Centonze D
    PLoS One; 2013; 8(1):e54666. PubMed ID: 23355887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mixed-Lineage Kinase Inhibitor URMC-099 Protects Hippocampal Synapses in Experimental Autoimmune Encephalomyelitis.
    Bellizzi MJ; Hammond JW; Li H; Gantz Marker MA; Marker DF; Freeman RS; Gelbard HA
    eNeuro; 2018; 5(6):. PubMed ID: 30627663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple pathological mechanisms contribute to hippocampal damage in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Kyran EL; Robinson C; Kocovski P; Li Z; Dang PT; Hale MW; Orian JM
    Neuroreport; 2018 Jan; 29(1):19-24. PubMed ID: 29194293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexone.
    Kwilasz AJ; Todd LS; Duran-Malle JC; Schrama AEW; Mitten EH; Larson TA; Clements MA; Harris KM; Litwiler ST; Wang X; Van Dam AM; Maier SF; Rice KC; Watkins LR; Barrientos RM
    Behav Brain Res; 2021 Jan; 396():112896. PubMed ID: 32905811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype.
    Hou B; Zhang Y; Liang P; He Y; Peng B; Liu W; Han S; Yin J; He X
    Cell Death Dis; 2020 May; 11(5):377. PubMed ID: 32415059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.
    Bonfiglio T; Olivero G; Merega E; Di Prisco S; Padolecchia C; Grilli M; Milanese M; Di Cesare Mannelli L; Ghelardini C; Bonanno G; Marchi M; Pittaluga A
    PLoS One; 2017; 12(1):e0170825. PubMed ID: 28125677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegeneration in autoimmune CNS inflammation.
    Herz J; Zipp F; Siffrin V
    Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior.
    Kocovski P; Tabassum-Sheikh N; Marinis S; Dang PT; Hale MW; Orian JM
    Front Immunol; 2021; 12():639650. PubMed ID: 34177891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced GABAergic Tonic Inhibition Reduces Intrinsic Excitability of Hippocampal CA1 Pyramidal Cells in Experimental Autoimmune Encephalomyelitis.
    Kammel LG; Wei W; Jami SA; Voskuhl RR; O'Dell TJ
    Neuroscience; 2018 Dec; 395():89-100. PubMed ID: 30447391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.
    Centonze D; Muzio L; Rossi S; Cavasinni F; De Chiara V; Bergami A; Musella A; D'Amelio M; Cavallucci V; Martorana A; Bergamaschi A; Cencioni MT; Diamantini A; Butti E; Comi G; Bernardi G; Cecconi F; Battistini L; Furlan R; Martino G
    J Neurosci; 2009 Mar; 29(11):3442-52. PubMed ID: 19295150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal damage in mouse and human forms of systemic autoimmune disease.
    Ballok DA; Woulfe J; Sur M; Cyr M; Sakic B
    Hippocampus; 2004; 14(5):649-61. PubMed ID: 15301441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.